Squarepoint
AGN

Squarepoint’s Allergan plc AGN Stock Holding History

Squarepoint’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-42,327
Closed -$7.5M – 2685
2020
Q1 		$7.5M Sell
42,327
-157,442
-79% -$29.6M 0.19% 116
2019
Q4 		$38.2M Buy
199,769
+46,963
+31% +$8.47M 0.23% 62
2019
Q3 		$25.7M Buy
152,806
+589
+0.4% +$96K 0.23% 98
2019
Q2 		$25.5M Buy
152,217
+108,231
+246% +$15M 0.25% 89
2019
Q1 		$6.44M Sell
43,986
-589,591
-93% -$85.5M 0.07% 347
2018
Q4 		$84.7M Buy
633,577
+472,695
+294% +$77.5M 0.99% 4
2018
Q3 		$30.6M Buy
160,882
+61,801
+62% +$11.4M 0.37% 45
2018
Q2 		$16.5M Sell
99,081
-9,250
-9% -$1.49M 0.22% 116
2018
Q1 		$18.2M Buy
108,331
+82,121
+313% +$13.8M 0.29% 81
2017
Q4 		$4.29M Sell
26,210
-90,580
-78% -$16.3M 0.07% 314
2017
Q3 		$23.9M Buy
116,790
+109,473
+1,496% +$25.5M 0.46% 34
2017
Q2 		$1.78M Buy
+7,317
New +$1.72M 0.04% 556
2017
Q1 		– Sell
-57,265
Closed -$12M – 2085
2016
Q4 		$12M Buy
57,265
+54,573
+2,027% +$11.3M 0.49% 31
2016
Q3 		$620K Sell
2,692
-16,057
-86% -$3.92M 0.04% 493
2016
Q2 		$4.33M Sell
18,749
-14,798
-44% -$3.41M 0.27% 70
2016
Q1 		$8.99M Buy
+33,547
New +$9.6M 0.7% 10
2015
Q4 		– Sell
-4,248
Closed -$1.16M – 1329
2015
Q3 		$1.16M Buy
+4,248
New +$1.3M 0.29% 100
2015
Q1 		– Sell
-1,420
Closed -$366K – 508
2014
Q4 		$366K Buy
+1,420
New +$355K 0.35% 111

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Squarepoint's AGN Position: Q2 2020 in Review

Squarepoint sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 42,327 shares — an estimated $7.5M sold.

Squarepoint first reported a position in AGN in Q4 2014 and held it in 18 quarters. The position peaked at $84.7M in Q4 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Squarepoint reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Squarepoint sold 42,327 Allergan plc shares in Q2 2020, an estimated $7.5M.
  • Squarepoint first reported a position in Allergan plc in Q4 2014 and held it in 18 quarters.
  • Squarepoint's Allergan plc position peaked at $84.7M in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.